-
Je něco špatně v tomto záznamu ?
Local endothelial DNA repair deficiency causes aging-resembling endothelial-specific dysfunction
PK. Bautista-Niño, E. Portilla-Fernandez, E. Rubio-Beltrán, JJ. van der Linden, R. de Vries, R. van Veghel, M. de Boer, M. Durik, Y. Ridwan, R. Brandt, J. Essers, RI. Menzies, R. Thomas, A. de Bruin, DJ. Duncker, HMM. van Beusekom, M. Ghanbari,...
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem
Grantová podpora
CH/12/4/29762
British Heart Foundation - United Kingdom
FS/15/60/31510
British Heart Foundation - United Kingdom
P01 AG017242
NIA NIH HHS - United States
PubMed
32202295
DOI
10.1042/cs20190124
Knihovny.cz E-zdroje
- MeSH
- cévní endotel metabolismus patologie patofyziologie MeSH
- DNA vazebné proteiny nedostatek genetika MeSH
- endonukleasy nedostatek genetika MeSH
- endoteliální buňky metabolismus patologie MeSH
- inhibitor p21 cyklin-dependentní kinasy genetika metabolismus MeSH
- kapilární permeabilita MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- oprava DNA * MeSH
- oxid dusnatý metabolismus MeSH
- poškození DNA * MeSH
- stárnutí buněk genetika MeSH
- stárnutí genetika metabolismus patologie MeSH
- superoxidy metabolismus MeSH
- synthasa oxidu dusnatého, typ III metabolismus MeSH
- tuhost cévní stěny MeSH
- vazodilatace MeSH
- věkové faktory MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
We previously identified genomic instability as a causative factor for vascular aging. In the present study, we determined which vascular aging outcomes are due to local endothelial DNA damage, which was accomplished by genetic removal of ERCC1 (excision repair cross-complementation group 1) DNA repair in mice (EC-knockout (EC-KO) mice). EC-KO showed a progressive decrease in microvascular dilation of the skin, increased microvascular leakage in the kidney, decreased lung perfusion, and increased aortic stiffness compared with wild-type (WT). EC-KO showed expression of DNA damage and potential senescence marker p21 exclusively in the endothelium, as demonstrated in aorta. Also the kidney showed p21-positive cells. Vasodilator responses measured in organ baths were decreased in aorta, iliac and coronary artery EC-KO compared with WT, of which coronary artery was the earliest to be affected. Nitric oxide-mediated endothelium-dependent vasodilation was abolished in aorta and coronary artery, whereas endothelium-derived hyperpolarization and responses to exogenous nitric oxide (NO) were intact. EC-KO showed increased superoxide production compared with WT, as measured in lung tissue, rich in endothelial cells (ECs). Arterial systolic blood pressure (BP) was increased at 3 months, but normal at 5 months, at which age cardiac output (CO) was decreased. Since no further signs of cardiac dysfunction were detected, this decrease might be an adaptation to prevent an increase in BP. In summary, a selective DNA repair defect in the endothelium produces features of age-related endothelial dysfunction, largely attributed to loss of endothelium-derived NO. Increased superoxide generation might contribute to the observed changes affecting end organ perfusion, as demonstrated in kidney and lung.
Centre for Cardiovascular Science The University of Edinburgh Edinburgh U K
Department of Epidemiology Erasmus University Medical Center Rotterdam The Netherlands
Department of Molecular Genetics Erasmus University Medical Center Rotterdam The Netherlands
Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow U K
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025080
- 003
- CZ-PrNML
- 005
- 20201222153656.0
- 007
- ta
- 008
- 201125s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1042/CS20190124 $2 doi
- 035 __
- $a (PubMed)32202295
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Bautista-Niño, Paula K $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Fundacion Cardiovascular de Colombia FCV, Dept. of Cardiology, Bucaramanga, Colombia.
- 245 10
- $a Local endothelial DNA repair deficiency causes aging-resembling endothelial-specific dysfunction / $c PK. Bautista-Niño, E. Portilla-Fernandez, E. Rubio-Beltrán, JJ. van der Linden, R. de Vries, R. van Veghel, M. de Boer, M. Durik, Y. Ridwan, R. Brandt, J. Essers, RI. Menzies, R. Thomas, A. de Bruin, DJ. Duncker, HMM. van Beusekom, M. Ghanbari, JHJ. Hoeijmakers, R. Sedlacek, RM. Touyz, AC. Montezano, I. van der Pluijm, AHJ. Danser, KA. Haanes, AJM. Roks,
- 520 9_
- $a We previously identified genomic instability as a causative factor for vascular aging. In the present study, we determined which vascular aging outcomes are due to local endothelial DNA damage, which was accomplished by genetic removal of ERCC1 (excision repair cross-complementation group 1) DNA repair in mice (EC-knockout (EC-KO) mice). EC-KO showed a progressive decrease in microvascular dilation of the skin, increased microvascular leakage in the kidney, decreased lung perfusion, and increased aortic stiffness compared with wild-type (WT). EC-KO showed expression of DNA damage and potential senescence marker p21 exclusively in the endothelium, as demonstrated in aorta. Also the kidney showed p21-positive cells. Vasodilator responses measured in organ baths were decreased in aorta, iliac and coronary artery EC-KO compared with WT, of which coronary artery was the earliest to be affected. Nitric oxide-mediated endothelium-dependent vasodilation was abolished in aorta and coronary artery, whereas endothelium-derived hyperpolarization and responses to exogenous nitric oxide (NO) were intact. EC-KO showed increased superoxide production compared with WT, as measured in lung tissue, rich in endothelial cells (ECs). Arterial systolic blood pressure (BP) was increased at 3 months, but normal at 5 months, at which age cardiac output (CO) was decreased. Since no further signs of cardiac dysfunction were detected, this decrease might be an adaptation to prevent an increase in BP. In summary, a selective DNA repair defect in the endothelium produces features of age-related endothelial dysfunction, largely attributed to loss of endothelium-derived NO. Increased superoxide generation might contribute to the observed changes affecting end organ perfusion, as demonstrated in kidney and lung.
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a stárnutí $x genetika $x metabolismus $x patologie $7 D000375
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kapilární permeabilita $7 D002199
- 650 _2
- $a stárnutí buněk $x genetika $7 D016922
- 650 _2
- $a inhibitor p21 cyklin-dependentní kinasy $x genetika $x metabolismus $7 D050759
- 650 12
- $a poškození DNA $7 D004249
- 650 12
- $a oprava DNA $7 D004260
- 650 _2
- $a DNA vazebné proteiny $x nedostatek $x genetika $7 D004268
- 650 _2
- $a endonukleasy $x nedostatek $x genetika $7 D004720
- 650 _2
- $a endoteliální buňky $x metabolismus $x patologie $7 D042783
- 650 _2
- $a cévní endotel $x metabolismus $x patologie $x patofyziologie $7 D004730
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a oxid dusnatý $x metabolismus $7 D009569
- 650 _2
- $a synthasa oxidu dusnatého, typ III $x metabolismus $7 D052250
- 650 _2
- $a superoxidy $x metabolismus $7 D013481
- 650 _2
- $a tuhost cévní stěny $7 D059289
- 650 _2
- $a vazodilatace $7 D014664
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Portilla-Fernandez, Eliana $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Rubio-Beltrán, Eloisa $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a van der Linden, Janette J $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a de Vries, René $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a van Veghel, Richard $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a de Boer, Martine $u Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Durik, Matej $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Pediatric and Adolescent Medicine, Mayo Clinic College of Medicine, Rochester, MN, U.S.A.
- 700 1_
- $a Ridwan, Yanto $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Brandt, Renata $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Essers, Jeroen $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Menzies, Robert I $u Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, U.K.
- 700 1_
- $a Thomas, Rachel $u Dutch Molecular Pathology Centre, Faculty of Veterinary Medicine, Department of Pathobiology, Utrecht University, Utrecht, The Netherlands.
- 700 1_
- $a de Bruin, Alain $u Dutch Molecular Pathology Centre, Faculty of Veterinary Medicine, Department of Pathobiology, Utrecht University, Utrecht, The Netherlands.
- 700 1_
- $a Duncker, Dirk J $u Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a van Beusekom, Heleen M M $u Division of Experimental Cardiology, Department of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Ghanbari, Mohsen $u Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Hoeijmakers, Jan H J $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. CECAD Forschungszentrum, Universität zu Köln, Cologne, Germany. Princess Máxima Center for Pediatric Oncology, ONCODE Institute, Utrecht, The Netherlands.
- 700 1_
- $a Sedlacek, Radislav $u Laboratory of Transgenic Models of Diseases and Czech Centre for Phenogenomics, Institute of Molecular Genetics of the ASCR, Prague, Czech Republic.
- 700 1_
- $a Touyz, Rhian M $u Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.
- 700 1_
- $a Montezano, Augusto C $u Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.
- 700 1_
- $a van der Pluijm, Ingrid $u Department of Molecular Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Danser, A H Jan $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 700 1_
- $a Haanes, Kristian A $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands. Department of Clinical Experimental Research, Glostrup Research Institute, Copenhagen University Hospital, Copenhagen, Denmark.
- 700 1_
- $a Roks, Anton J M $u Division of Vascular Medicine and Pharmacology, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
- 773 0_
- $w MED00009494 $t Clinical science (London, England : 1979) $x 1470-8736 $g Roč. 134, č. 7 (2020), s. 727-746
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32202295 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222153652 $b ABA008
- 999 __
- $a ok $b bmc $g 1599225 $s 1115766
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 134 $c 7 $d 727-746 $e 20200417 $i 1470-8736 $m Clinical science (1979) $n Clin Sci (Lond) $x MED00009494
- GRA __
- $a CH/12/4/29762 $p British Heart Foundation $2 United Kingdom
- GRA __
- $a FS/15/60/31510 $p British Heart Foundation $2 United Kingdom
- GRA __
- $a P01 AG017242 $p NIA NIH HHS $2 United States
- LZP __
- $a Pubmed-20201125